Does DAPAGLIFLOZIN PROPANEDIOL Cause Off label use? 165 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 165 reports of Off label use have been filed in association with DAPAGLIFLOZIN PROPANEDIOL (FARXIGA). This represents 1.0% of all adverse event reports for DAPAGLIFLOZIN PROPANEDIOL.
165
Reports of Off label use with DAPAGLIFLOZIN PROPANEDIOL
1.0%
of all DAPAGLIFLOZIN PROPANEDIOL reports
1
Deaths
26
Hospitalizations
How Dangerous Is Off label use From DAPAGLIFLOZIN PROPANEDIOL?
Of the 165 reports, 1 (0.6%) resulted in death, 26 (15.8%) required hospitalization, and 5 (3.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN PROPANEDIOL. However, 165 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN PROPANEDIOL Cause?
Death (3,443)
Fungal infection (1,204)
Blood glucose increased (778)
Weight decreased (777)
Urinary tract infection (583)
Dizziness (582)
Diabetic ketoacidosis (547)
Nausea (460)
Fatigue (442)
Pollakiuria (388)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which DAPAGLIFLOZIN PROPANEDIOL Alternatives Have Lower Off label use Risk?
DAPAGLIFLOZIN PROPANEDIOL vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN PROPANEDIOL vs DAPRODUSTAT
DAPAGLIFLOZIN PROPANEDIOL vs DAPSONE
DAPAGLIFLOZIN PROPANEDIOL vs DAPTOMYCIN
DAPAGLIFLOZIN PROPANEDIOL vs DARATUMUMAB